You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

L-dopa

Showing 1 - 25 of 3,302
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Anhedonia, Depression Trial in Atlanta (Carbidopa Levodopa, Placebo)

Not yet recruiting
  • Anhedonia
  • Depression
  • Carbidopa Levodopa
  • Placebo
  • Atlanta, Georgia
    Emory University Hospital
Oct 4, 2023

An Imaging Agent With Positron Emission Tomography/Magnetic

Recruiting
  • Recurrent Soft Tissue Sarcoma
  • +2 more
  • Fluorodopa F 18
  • +4 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Jan 4, 2023

PET Scanning in Parkinson s Disease

Recruiting
  • Schizophrenia
  • Parkinson's Disease
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 25, 2023

MDD, Dysthymia, Depression Trial in New York (L-DOPA, Placebo Oral Tablet)

Suspended
  • Major Depressive Disorder
  • +2 more
  • L-DOPA
  • Placebo Oral Tablet
  • New York, New York
    New York State Psychiatric Institute
Jan 26, 2022

Glioblastoma Trial in Rochester (radiation, procedure, drug, other)

Recruiting
  • Glioblastoma
  • Accelerated Hypofractionated Radiation Therapy
  • +8 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Mar 24, 2023

Disorder of Consciousness, Traumatic Brain Injury Trial in New York (Amantadine + L-DOPA, NMDA blocker)

Suspended
  • Disorder of Consciousness
  • Traumatic Brain Injury
  • Amantadine + L-DOPA
  • NMDA blocker
  • New York, New York
    Weill Cornell Medicine
Sep 27, 2022

Depressive Disorder, Major Trial (L-dopa/Carbidopa, Placebo)

Not yet recruiting
  • Depressive Disorder, Major
  • (no location specified)
Jun 11, 2023

PTSD, Post Traumatic Stress Disorder Trial in Austin, Madison (L-DOPA, Placebo)

Recruiting
  • PTSD
  • Post Traumatic Stress Disorder
  • L-DOPA
  • Placebo
  • Austin, Texas
  • +1 more
Jan 12, 2023

Parkinson Trial in Dupnitsa (Opicapone 50 mg, Placebo)

Recruiting
  • Parkinson
  • Opicapone 50 mg
  • Placebo
  • Dupnitsa, Bulgaria
    Medical Centre "Asklepii", OOD
Jul 20, 2021

Malignant Glioma Trial in Rochester (Fluorine-18-L-dihydroxyphenylalanine)

Active, not recruiting
  • Malignant Glioma
  • Rochester, Minnesota
    Mayo Clinic
Oct 10, 2022

Spinal Cord Injuries Trial in Louisville (5HTP, L-DOPA, Placebo oral tablet)

Recruiting
  • Spinal Cord Injuries
  • Louisville, Kentucky
    University of Louisville, Kentucky Spinal Cord Injury Research C
Aug 27, 2021

Depression, Anhedonia Trial in Atlanta (Carbidopa Levodopa, Placebo)

Recruiting
  • Depression
  • Anhedonia
  • Carbidopa Levodopa
  • Placebo
  • Atlanta, Georgia
    Emory University Hospital
Mar 3, 2022

Depressive Disorder Trial in New York (Carbidopa/levodopa, Placebo, Exercise training)

Suspended
  • Depressive Disorder
  • New York, New York
    New York State Psychiatric Institute
Jan 26, 2022

Late Life Depression, Cognitive Decline, Depressive Disorder, Treatment-Resistant Trial in Nashville (L-Dopa, Placebo)

Recruiting
  • Late Life Depression
  • +4 more
  • L-Dopa
  • Placebo
  • Nashville, Tennessee
    Vanderbilt Psychiatric Hospital
Feb 23, 2022

Depression, Cognitive Impairment, Gait Impairment Trial in New York (Carbidopa/levodopa, Placebo)

Suspended
  • Depression
  • +2 more
  • New York, New York
    New York State Psychiatric Institute
Jan 26, 2022

Parkinson Disease Trial (Opicapone, L-DOPA/DDCI)

Not yet recruiting
  • Parkinson Disease
  • (no location specified)
Oct 13, 2021

Parkinson's Disease Trial in United States (AFQ056 with L-dopa, Placebo)

Completed
  • Parkinson's Disease
  • AFQ056 with L-dopa
  • Placebo
  • Sunnyvale, California
  • +3 more
Dec 15, 2020

Sub-acute Back Pain Trial in Chicago (Naproxen, Carbidopa/Levodopa, Placebo)

Completed
Has Results
  • Sub-acute Back Pain
  • Chicago, Illinois
    Northwestern University Feinberg School of Medicine
Mar 2, 2021

Brain Metastases, MRI Trial in Angers (F-DOPA PET/CT)

Recruiting
  • Brain Metastases
  • MRI
  • F-DOPA PET/CT
  • Angers, France
  • +1 more
Dec 28, 2021

Hyperinsulinism Trial in Saint Louis (18F-Fluoro Dopa PET/MRI Imaging)

Recruiting
  • Hyperinsulinism
  • 18F-Fluoro Dopa PET/MRI Imaging
  • Saint Louis, Missouri
    Washington University
Oct 8, 2021

Opicapone Plus Standard of Care in Elderly Parkinson's Disease

Completed
  • Parkinson Disease
  • Norwich, Norfolk, United Kingdom
    Norfolk&Norwich University Hospitals
Oct 1, 2021

Parkinson's Disease Trial in Australia (Placebo, L-dopa 35 mg, L-dopa 70mg)

Completed
Has Results
  • Parkinson's Disease
  • Placebo
  • +4 more
  • Sydney, New South Wales, Australia
  • +4 more
Jul 27, 2020

Substance Abuse Pre-Treatment Screening Study

Recruiting
  • Cocaine Abuse
  • +4 more
  • Houston, Texas
    University of Texas Medical School- Houston, Dept. of Psychiatry
Oct 12, 2021

Parkinson Disease, Dyskinesia, Medication-Induced, L-Dopa Causing Adverse Effects in Therapeutic Use Trial (AV-101, Placebo)

Not yet recruiting
  • Parkinson Disease
  • +2 more
  • (no location specified)
May 25, 2021

Medication-Induced Dyskinesia Trial in Sweden (NLX-112, Placebo)

Recruiting
  • Medication-Induced Dyskinesia
  • Gothenburg, Sweden
  • +4 more
Nov 24, 2021